278 related articles for article (PubMed ID: 24809501)
1. Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.
Galletti G; Portella L; Tagawa ST; Kirby BJ; Giannakakou P; Nanus DM
Mol Diagn Ther; 2014 Aug; 18(4):389-402. PubMed ID: 24809501
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
[TBL] [Abstract][Full Text] [Related]
4. Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.
Suh YS; Joung JY; Kim SH; Seo HK; Chung J; Lee KH
Biomed Res Int; 2017; 2017():7206307. PubMed ID: 29230413
[TBL] [Abstract][Full Text] [Related]
5. Functional Studies on Viable Circulating Tumor Cells.
Pantel K; Alix-Panabières C
Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
[TBL] [Abstract][Full Text] [Related]
6. Tumorigenic potential of circulating prostate tumor cells.
Carvalho FL; Simons BW; Antonarakis ES; Rasheed Z; Douglas N; Villegas D; Matsui W; Berman DM
Oncotarget; 2013 Mar; 4(3):413-21. PubMed ID: 23530114
[TBL] [Abstract][Full Text] [Related]
7. [Detection of circulating tumor cells from peripheral blood in prostate cancer].
Thalgott M; Heck MM; Pantel K
Urologe A; 2014 Apr; 53(4):509-13. PubMed ID: 24671249
[TBL] [Abstract][Full Text] [Related]
8. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
[TBL] [Abstract][Full Text] [Related]
9. Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer.
Cimadamore A; Aurilio G; Nolé F; Massari F; Scarpelli M; Santoni M; Lopez-Beltran A; Cheng L; Montironi R
Cells; 2020 Jun; 9(6):. PubMed ID: 32575429
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells in prostate cancer: beyond enumeration.
Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
[TBL] [Abstract][Full Text] [Related]
11. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
Cann GM; Gulzar ZG; Cooper S; Li R; Luo S; Tat M; Stuart S; Schroth G; Srinivas S; Ronaghi M; Brooks JD; Talasaz AH
PLoS One; 2012; 7(11):e49144. PubMed ID: 23145101
[TBL] [Abstract][Full Text] [Related]
12. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
13. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.
Wu P; Sokoll LJ; Kudrolli TA; Chowdhury WH; Ma R; Liu MM; Rodriguez R; Lupold SE
Prostate; 2014 Sep; 74(13):1286-1296. PubMed ID: 25065656
[TBL] [Abstract][Full Text] [Related]
14. Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells.
Mout L; van Dessel LF; Kraan J; de Jong AC; Neves RPL; Erkens-Schulze S; Beaufort CM; Sieuwerts AM; van Riet J; Woo TLC; de Wit R; Sleijfer S; Hamberg P; Sandberg Y; Te Boekhorst PAW; van de Werken HJG; Martens JWM; Stoecklein NH; van Weerden WM; Lolkema MP
Eur J Cancer; 2021 Jun; 150():179-189. PubMed ID: 33932725
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
Sun YF; Yang XR; Zhou J; Qiu SJ; Fan J; Xu Y
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1151-73. PubMed ID: 21681690
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
[TBL] [Abstract][Full Text] [Related]
17. Clinical indications for, and the future of, circulating tumor cells.
Moon DH; Lindsay DP; Hong S; Wang AZ
Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Ciccarese C; Montironi R; Fiorentino M; Martignoni G; Brunelli M; Iacovelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Moch H; Tortora G; Massari F
Curr Drug Metab; 2017; 18(8):692-699. PubMed ID: 28524006
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Application and Potential Roles of Circulating Tumor Cells in Bladder Cancer and Prostate Cancer.
Yan H; Dittmar F; Schagdarsurengin U; Wagenlehner F
Urology; 2020 Nov; 145():30-37. PubMed ID: 32634447
[TBL] [Abstract][Full Text] [Related]
20. Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment.
Yang M; Zhang X; Guo L; Liu X; Wu J; Zhu H
Biomed Res Int; 2021; 2021():6230826. PubMed ID: 33506020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
